Published Online: May 19, 2014. doi:10.1001/jamainternmed.2014.1803.
Study concept and design: Butala, Balcezak, Horwitz.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Butala, Dziura, Reynolds, Horwitz.
Critical revision of the manuscript for important intellectual content: Butala, Johnson, Dziura, Reynolds, Balcezak, Inzucchi.
Statistical analysis: Johnson, Dziura, Reynolds, Horwitz.
Obtained funding: Horwitz.
Administrative, technical, or material support: Butala, Balcezak, Horwitz.
Study supervision: Balcezak, Inzucchi, Horwitz.
Conflict of Interest Disclosures: Dr Inzucchi serves on a Data Safety Monitoring Board for Novo Nordisk, a manufacturer of insulin products used in the hospital setting. No other disclosures are reported.
Funding/Support: Dr Horwitz is supported by the National Institute on Aging (K08 AG038336) and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.
Role of the Sponsors: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: The authors thank the Yale–New Haven Hospital diabetes management team: Gael Ulisse, APRN, Helen Psarakis, APRN, Anne Kaisen, APRN, and the Yale Endocrine Fellows, for providing high-quality clinical care to the patients in this study, and Janis Bozzo, MSN, RN, Decision Support, Yale–New Haven Health System, for assistance in obtaining study data. None of these individuals received compensation for their contribution.